Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Bryan Haugen

Concepts (516)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
101
2026
380
16.290
 Why?
Adenocarcinoma, Follicular
20
2026
43
3.640
 Why?
Iodine Radioisotopes
29
2025
138
3.580
 Why?
Thyroid Nodule
18
2025
67
3.460
 Why?
Carcinoma, Papillary
24
2017
83
3.240
 Why?
Thyroid Gland
26
2018
93
3.100
 Why?
Endocrinology
10
2020
77
2.880
 Why?
Thyrotropin
30
2023
120
2.560
 Why?
Carcinoma
10
2025
231
1.730
 Why?
Thyroid Diseases
9
2026
45
1.600
 Why?
Thyroidectomy
17
2024
96
1.320
 Why?
Retinoid X Receptors
11
2011
42
1.200
 Why?
Antineoplastic Agents
15
2022
2231
1.180
 Why?
Retinoids
7
2011
36
1.130
 Why?
Hypothyroidism
8
2023
68
1.110
 Why?
Tetrahydronaphthalenes
6
2015
34
1.100
 Why?
Thyroid Carcinoma, Anaplastic
6
2019
37
1.090
 Why?
Carcinoma, Neuroendocrine
2
2025
38
1.010
 Why?
Thyroxine
12
2023
67
1.010
 Why?
Biomarkers, Tumor
15
2024
1339
0.970
 Why?
Receptors, Retinoic Acid
7
2004
44
0.960
 Why?
Carcinoma, Medullary
2
2025
16
0.900
 Why?
Biopsy, Fine-Needle
9
2021
79
0.900
 Why?
NF-kappa B
3
2015
676
0.890
 Why?
Ultrasonography
9
2026
795
0.870
 Why?
Lymphatic Metastasis
7
2024
338
0.840
 Why?
Carcinoma, Papillary, Follicular
4
2014
8
0.840
 Why?
Thyroglobulin
9
2026
29
0.820
 Why?
Neoplasm Proteins
6
2013
445
0.790
 Why?
Transcription Factors
15
2014
1747
0.770
 Why?
Gene Expression Profiling
6
2020
1794
0.760
 Why?
Cell Line, Tumor
20
2023
3565
0.760
 Why?
Humans
142
2026
147293
0.750
 Why?
Struma Ovarii
2
2014
8
0.720
 Why?
Radiopharmaceuticals
3
2012
210
0.710
 Why?
Proto-Oncogene Proteins B-raf
3
2023
230
0.660
 Why?
Thiazolidinediones
4
2018
143
0.650
 Why?
Neoplasm Invasiveness
6
2017
512
0.640
 Why?
Pituitary Gland
6
2011
149
0.640
 Why?
Promoter Regions, Genetic
14
2018
1253
0.640
 Why?
Thyroid Hormones
5
2023
69
0.620
 Why?
History, 20th Century
7
2018
333
0.610
 Why?
Oncogene Proteins, Fusion
2
2019
212
0.610
 Why?
Lymph Nodes
5
2018
514
0.590
 Why?
Cell Differentiation
5
2020
2054
0.570
 Why?
Triiodothyronine
4
2017
55
0.550
 Why?
Neoplasm Metastasis
10
2015
695
0.550
 Why?
T-Lymphocytes, Regulatory
3
2015
415
0.550
 Why?
History, 21st Century
6
2018
227
0.530
 Why?
Proto-Oncogene Proteins p21(ras)
1
2019
256
0.520
 Why?
Hypothalamus
2
2011
164
0.520
 Why?
Neoplasm Recurrence, Local
8
2024
1166
0.520
 Why?
Recombinant Proteins
9
2009
1371
0.500
 Why?
Programmed Cell Death 1 Receptor
3
2016
268
0.500
 Why?
Mutation
11
2023
4130
0.490
 Why?
Societies, Medical
6
2020
914
0.490
 Why?
Neoplasm Staging
14
2021
1492
0.480
 Why?
Molecular Targeted Therapy
3
2015
444
0.470
 Why?
Drug Resistance, Neoplasm
4
2023
889
0.470
 Why?
Multimodal Imaging
2
2014
138
0.470
 Why?
Pharmacogenomic Testing
1
2016
63
0.460
 Why?
Ovarian Neoplasms
2
2014
599
0.460
 Why?
Protein-Tyrosine Kinases
1
2019
432
0.460
 Why?
DNA-Binding Proteins
13
2014
1488
0.450
 Why?
Databases, Genetic
1
2016
240
0.440
 Why?
Transcriptome
3
2020
1059
0.440
 Why?
Famous Persons
1
2014
7
0.430
 Why?
Terminology as Topic
1
2017
261
0.430
 Why?
Anticarcinogenic Agents
1
2015
63
0.420
 Why?
Tomography, Emission-Computed, Single-Photon
2
2014
104
0.420
 Why?
Physician Executives
1
2014
30
0.420
 Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2014
980
0.420
 Why?
Data Collection
3
2016
652
0.410
 Why?
Hyperthyroidism
2
2012
22
0.410
 Why?
Gene Expression Regulation, Neoplastic
7
2018
1457
0.400
 Why?
Mice
29
2023
18491
0.400
 Why?
Neoplasm Transplantation
5
2019
246
0.400
 Why?
Genes, Tumor Suppressor
1
2014
86
0.400
 Why?
Immunotherapy, Adoptive
1
2017
356
0.400
 Why?
Gene Expression
2
2012
1481
0.400
 Why?
Combined Modality Therapy
8
2021
1281
0.390
 Why?
Interleukin-8
1
2014
269
0.380
 Why?
Cell Proliferation
10
2023
2529
0.370
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
2001
0.370
 Why?
Medical Oncology
1
2016
344
0.370
 Why?
Middle Aged
38
2026
36821
0.360
 Why?
Research
1
2016
434
0.360
 Why?
Neovascularization, Pathologic
1
2014
287
0.360
 Why?
Phenylurea Compounds
2
2024
122
0.360
 Why?
Pituitary Gland, Anterior
4
2002
37
0.350
 Why?
Proteomics
3
2010
1203
0.350
 Why?
Radiotherapy, Adjuvant
2
2012
222
0.350
 Why?
Quinolines
2
2024
192
0.350
 Why?
Female
55
2026
80076
0.350
 Why?
RNA, Messenger
15
2012
2812
0.350
 Why?
Antigens, Neoplasm
2
2026
273
0.350
 Why?
Animals
33
2023
38410
0.340
 Why?
T-Lymphocytes
3
2026
2017
0.330
 Why?
Bone Neoplasms
2
2012
272
0.330
 Why?
Practice Guidelines as Topic
5
2020
1598
0.330
 Why?
Decision Support Techniques
1
2015
480
0.330
 Why?
Telomerase
5
2019
250
0.320
 Why?
Lymphocytes, Tumor-Infiltrating
2
2026
156
0.320
 Why?
Aged
27
2026
26514
0.320
 Why?
DNA, Neoplasm
2
2008
163
0.320
 Why?
Protein Kinase Inhibitors
3
2024
984
0.320
 Why?
Blotting, Western
8
2014
1186
0.320
 Why?
PPAR gamma
3
2009
182
0.310
 Why?
Male
48
2026
73950
0.310
 Why?
Prognosis
12
2024
4383
0.310
 Why?
Carrier Proteins
1
2014
731
0.300
 Why?
MAP Kinase Kinase 2
1
2009
28
0.300
 Why?
MAP Kinase Kinase 1
1
2009
70
0.290
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
14
0.290
 Why?
Cell Culture Techniques
2
2009
375
0.290
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2009
35
0.290
 Why?
Forkhead Transcription Factors
1
2010
210
0.280
 Why?
Adult
36
2026
41405
0.270
 Why?
Iodide Peroxidase
2
2005
35
0.270
 Why?
Signal Transduction
6
2023
5272
0.270
 Why?
Hormone Replacement Therapy
2
2020
109
0.260
 Why?
Receptors, Cytoplasmic and Nuclear
2
2009
212
0.260
 Why?
Treatment Outcome
18
2024
11947
0.260
 Why?
Quinazolines
1
2009
266
0.260
 Why?
MAP Kinase Signaling System
1
2009
308
0.260
 Why?
Cell Transformation, Neoplastic
2
2012
340
0.260
 Why?
Benzodioxoles
1
2009
162
0.250
 Why?
Adenoma
3
2025
219
0.250
 Why?
S100 Proteins
1
2006
35
0.240
 Why?
Adenoma, Oxyphilic
2
2024
7
0.240
 Why?
Diagnosis, Differential
6
2025
1518
0.240
 Why?
Apoptosis
4
2012
2454
0.240
 Why?
Disease-Free Survival
5
2021
779
0.240
 Why?
Lipoprotein Lipase
2
2004
56
0.240
 Why?
Evidence-Based Medicine
3
2020
742
0.230
 Why?
Genetic Heterogeneity
1
2026
66
0.230
 Why?
Tamoxifen
3
2023
193
0.230
 Why?
Retrospective Studies
12
2025
17560
0.230
 Why?
Polymorphism, Single Nucleotide
3
2026
2223
0.230
 Why?
Molecular Diagnostic Techniques
2
2021
104
0.230
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2025
14
0.230
 Why?
Hamartoma Syndrome, Multiple
1
2025
16
0.230
 Why?
Adenomatous Polyposis Coli
1
2025
40
0.220
 Why?
Oligonucleotide Array Sequence Analysis
3
2014
751
0.220
 Why?
Mice, Nude
5
2018
680
0.220
 Why?
Tomography, X-Ray Computed
3
2018
2791
0.220
 Why?
Melanoma
2
2009
774
0.220
 Why?
Tumor Cells, Cultured
8
2009
891
0.220
 Why?
Goiter, Nodular
1
2004
2
0.210
 Why?
Retinoid X Receptor gamma
1
2004
5
0.210
 Why?
Galectin 3
1
2004
21
0.210
 Why?
Neoplasms
3
2016
2946
0.210
 Why?
Chromosomal Proteins, Non-Histone
2
2002
130
0.210
 Why?
United States
14
2025
16313
0.210
 Why?
Sensitivity and Specificity
6
2024
2017
0.210
 Why?
Dietary Fats
2
2004
309
0.210
 Why?
Immunohistochemistry
7
2020
1730
0.210
 Why?
Microtubule-Associated Proteins
2
2002
197
0.200
 Why?
Molecular Sequence Data
13
2006
2886
0.200
 Why?
Radionuclide Imaging
4
2010
116
0.200
 Why?
Cell Cycle
2
2023
600
0.200
 Why?
Drug Resistance
2
2022
145
0.190
 Why?
Cell Line
4
2022
2832
0.190
 Why?
Whole-Body Counting
2
2006
7
0.190
 Why?
Prospective Studies
12
2023
8164
0.180
 Why?
Cell Cycle Proteins
1
2006
633
0.180
 Why?
Benzoates
3
2009
51
0.180
 Why?
Genome-Wide Association Study
2
2026
1496
0.180
 Why?
Estrogen Receptor alpha
1
2023
154
0.180
 Why?
Aged, 80 and over
10
2024
8430
0.170
 Why?
Disease Models, Animal
4
2022
4604
0.170
 Why?
Cytodiagnosis
1
2021
31
0.170
 Why?
Reoperation
1
2024
644
0.170
 Why?
Consensus
3
2020
476
0.160
 Why?
Artificial Intelligence
1
2026
389
0.160
 Why?
Thyroid Hormone Resistance Syndrome
1
2000
1
0.160
 Why?
Base Sequence
11
2002
2175
0.160
 Why?
Estrogens
1
2023
368
0.160
 Why?
Xenograft Model Antitumor Assays
4
2020
939
0.160
 Why?
Genetic Predisposition to Disease
2
2026
2458
0.160
 Why?
Lymphoma
1
2002
253
0.160
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3
2010
143
0.150
 Why?
Breast Neoplasms
3
2023
2420
0.150
 Why?
CD8-Positive T-Lymphocytes
3
2016
932
0.150
 Why?
Adenocarcinoma
3
2017
928
0.150
 Why?
Vascular Endothelial Growth Factor A
1
2022
552
0.140
 Why?
Transfection
5
2005
930
0.140
 Why?
Nitriles
2
2010
211
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2024
1005
0.130
 Why?
Thyrotropin, beta Subunit
2
2011
5
0.130
 Why?
Receptors, Estrogen
1
2020
406
0.130
 Why?
Up-Regulation
1
2020
848
0.130
 Why?
Intercellular Adhesion Molecule-1
1
2017
132
0.130
 Why?
Neck
2
2015
109
0.130
 Why?
Tissue Extracts
1
2017
19
0.130
 Why?
Workflow
1
2018
183
0.130
 Why?
Algorithms
5
2018
1868
0.130
 Why?
Heterografts
2
2015
143
0.120
 Why?
Disease Progression
6
2020
2890
0.120
 Why?
Transcription Factor Pit-1
8
1999
26
0.120
 Why?
Parathyroidectomy
1
2016
9
0.120
 Why?
Enzyme Inhibitors
2
2010
822
0.120
 Why?
Tretinoin
1
1997
125
0.120
 Why?
Muscle, Skeletal
2
2004
1798
0.120
 Why?
Ligands
3
2009
675
0.110
 Why?
Prolactin
2
1999
88
0.110
 Why?
Colorado
3
2014
4591
0.110
 Why?
Caspase 7
1
2015
22
0.110
 Why?
Homeodomain Proteins
3
1999
525
0.110
 Why?
Larynx
1
2016
56
0.110
 Why?
Diet
1
2023
1284
0.110
 Why?
Bortezomib
1
2015
54
0.110
 Why?
Inhibitory Concentration 50
1
2015
91
0.110
 Why?
Information Storage and Retrieval
1
2016
123
0.110
 Why?
User-Computer Interface
1
2016
165
0.110
 Why?
Hypocalcemia
1
2015
40
0.110
 Why?
Taxoids
1
2015
116
0.110
 Why?
Radiation, Ionizing
1
2015
86
0.110
 Why?
Pharmacogenetics
1
2016
176
0.110
 Why?
Transcriptional Activation
2
1994
372
0.110
 Why?
Tumor Suppressor Protein p53
1
2019
536
0.110
 Why?
Laryngoscopy
1
2016
122
0.110
 Why?
Immunophenotyping
2
2015
325
0.110
 Why?
Double-Blind Method
2
2012
2080
0.110
 Why?
Guidelines as Topic
1
2016
268
0.110
 Why?
Risk Assessment
4
2024
3784
0.110
 Why?
Caspase 3
1
2015
242
0.100
 Why?
Societies, Scientific
1
2014
50
0.100
 Why?
Growth Hormone
1
1994
91
0.100
 Why?
NF-KappaB Inhibitor alpha
1
2014
50
0.100
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
267
0.100
 Why?
DNA Mutational Analysis
2
2020
414
0.100
 Why?
Histiocytoma, Benign Fibrous
1
1994
7
0.100
 Why?
Energy Metabolism
1
2000
936
0.100
 Why?
Predictive Value of Tests
2
2019
2133
0.100
 Why?
Immunotherapy
2
2016
672
0.100
 Why?
Diagnostic Techniques, Endocrine
1
2013
15
0.100
 Why?
I-kappa B Proteins
1
2014
75
0.100
 Why?
Graves Disease
2
2012
32
0.100
 Why?
Cell Death
1
2015
383
0.100
 Why?
Transduction, Genetic
1
2014
133
0.100
 Why?
Stilbenes
1
2013
30
0.100
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
105
0.100
 Why?
ROC Curve
1
2015
626
0.100
 Why?
Drug Resistance, Multiple
1
2013
25
0.100
 Why?
Preoperative Care
3
2024
381
0.100
 Why?
Transcription, Genetic
5
2011
1456
0.090
 Why?
Young Adult
6
2024
14437
0.090
 Why?
Genetic Variation
1
2018
995
0.090
 Why?
Observer Variation
1
2013
358
0.090
 Why?
Sirolimus
1
2014
283
0.090
 Why?
Contraindications
1
2012
90
0.090
 Why?
Registries
6
2015
2434
0.090
 Why?
T-Lymphocyte Subsets
2
2015
421
0.090
 Why?
Nuclear Proteins
1
1997
745
0.090
 Why?
Receptors, Thyroid Hormone
3
1996
18
0.090
 Why?
src-Family Kinases
1
2012
93
0.090
 Why?
Protein Isoforms
2
2004
398
0.090
 Why?
Thiazoles
1
2012
142
0.090
 Why?
Thyroiditis, Autoimmune
2
2020
16
0.080
 Why?
Glycoprotein Hormones, alpha Subunit
1
2011
23
0.080
 Why?
Mice, 129 Strain
1
2011
85
0.080
 Why?
Genomics
1
2016
839
0.080
 Why?
TOR Serine-Threonine Kinases
1
2014
456
0.080
 Why?
Oleanolic Acid
1
2010
9
0.080
 Why?
Polymerase Chain Reaction
4
2005
1046
0.080
 Why?
Cells, Cultured
3
2014
4169
0.080
 Why?
Adolescent
7
2024
22825
0.080
 Why?
Whole Body Imaging
1
2010
29
0.080
 Why?
Amino Acid Sequence
4
2006
2134
0.080
 Why?
Ribonucleases
3
2002
48
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
2
2008
110
0.080
 Why?
Lymphocyte Subsets
1
2010
78
0.080
 Why?
Weight Gain
2
2023
566
0.080
 Why?
Antibody Specificity
1
2010
180
0.080
 Why?
Somatostatin
1
2009
53
0.080
 Why?
Dopamine Agonists
1
2009
41
0.080
 Why?
Lymphoma, T-Cell
1
2009
31
0.080
 Why?
Quality Improvement
1
2018
1321
0.070
 Why?
Butadienes
1
2009
33
0.070
 Why?
Pilot Projects
1
2015
1912
0.070
 Why?
Diphosphonates
1
2010
68
0.070
 Why?
Sulfones
1
2010
127
0.070
 Why?
Endometrial Neoplasms
2
2002
205
0.070
 Why?
Calcium
1
2015
1197
0.070
 Why?
Bone Density Conservation Agents
1
2010
82
0.070
 Why?
Hysterectomy
1
2010
138
0.070
 Why?
Radiotherapy
1
2010
210
0.070
 Why?
Drug Screening Assays, Antitumor
1
2009
194
0.070
 Why?
Phosphorylation
2
2012
1721
0.070
 Why?
Pyrimidines
1
2012
532
0.070
 Why?
Benzamides
1
2009
227
0.070
 Why?
Membrane Proteins
1
2015
1171
0.070
 Why?
Drug Evaluation, Preclinical
1
2009
196
0.070
 Why?
Time Factors
3
2010
7173
0.070
 Why?
Flow Cytometry
1
2012
1172
0.070
 Why?
Lymphocyte Activation
1
2012
1140
0.070
 Why?
Postoperative Complications
2
2023
3022
0.070
 Why?
CD4-Positive T-Lymphocytes
2
2015
1162
0.070
 Why?
Enzyme Activation
1
2009
762
0.060
 Why?
Cohort Studies
5
2023
6099
0.060
 Why?
Autoantibodies
2
2013
1513
0.060
 Why?
Proportional Hazards Models
3
2023
1344
0.060
 Why?
Phenotype
3
2015
3216
0.060
 Why?
S100 Calcium Binding Protein A6
1
2006
1
0.060
 Why?
RNA, Small Interfering
1
2009
643
0.060
 Why?
Follow-Up Studies
5
2024
5476
0.060
 Why?
Reproducibility of Results
2
2019
3448
0.060
 Why?
Colonic Neoplasms
1
2008
258
0.060
 Why?
Fatty Acids, Nonesterified
1
2006
154
0.060
 Why?
Metformin
1
2009
329
0.060
 Why?
Pituitary Neoplasms
2
1999
190
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
106
0.060
 Why?
Proto-Oncogene Proteins c-ret
1
2025
41
0.060
 Why?
Neoplasm Grading
2
2018
313
0.060
 Why?
Chromatin Immunoprecipitation
1
2005
139
0.060
 Why?
Drug Delivery Systems
1
2009
381
0.060
 Why?
Inhibitor of Apoptosis Proteins
2
2002
46
0.060
 Why?
Glucocorticoids
1
2009
537
0.060
 Why?
RNA, Neoplasm
2
2002
83
0.060
 Why?
Postoperative Care
2
2018
299
0.050
 Why?
Blotting, Southern
2
1996
85
0.050
 Why?
Neck Dissection
1
2024
17
0.050
 Why?
Paclitaxel
1
2006
261
0.050
 Why?
Chromosome Mapping
2
1997
512
0.050
 Why?
Brain Neoplasms
1
2014
1338
0.050
 Why?
Recurrent Laryngeal Nerve Injuries
1
2024
16
0.050
 Why?
Organic Chemicals
1
2005
113
0.050
 Why?
Adjuvants, Pharmaceutic
1
2004
15
0.050
 Why?
Tomography, Emission-Computed
1
2004
71
0.050
 Why?
United Kingdom
1
2025
391
0.050
 Why?
PTEN Phosphohydrolase
1
2025
165
0.050
 Why?
Luciferases
1
2004
155
0.050
 Why?
DNA, Mitochondrial
1
2005
212
0.050
 Why?
Immunoprecipitation
1
2004
149
0.050
 Why?
Triglycerides
1
2006
529
0.050
 Why?
Heart Neoplasms
2
2015
56
0.050
 Why?
Probability
2
2021
309
0.050
 Why?
Cell Cycle Checkpoints
2
2016
97
0.050
 Why?
Dose-Response Relationship, Drug
2
2005
2030
0.050
 Why?
Professional Practice
1
2003
57
0.050
 Why?
Lymph Node Excision
1
2024
173
0.050
 Why?
Quality of Life
3
2022
3246
0.050
 Why?
Computers
1
2023
66
0.050
 Why?
National Institutes of Health (U.S.)
1
2023
149
0.050
 Why?
Protein Binding
1
2009
2249
0.050
 Why?
Genetic Testing
2
2018
493
0.050
 Why?
Poly A
1
2002
50
0.050
 Why?
5' Untranslated Regions
1
2002
60
0.040
 Why?
Cell Division
1
2004
758
0.040
 Why?
Gene Library
1
2002
122
0.040
 Why?
DNA, Complementary
1
2002
273
0.040
 Why?
Point Mutation
1
2002
245
0.040
 Why?
Endometrium
1
2002
64
0.040
 Why?
Thallium Radioisotopes
1
2001
8
0.040
 Why?
Organotechnetium Compounds
1
2001
12
0.040
 Why?
Thallium
1
2001
2
0.040
 Why?
Carcinoma, Endometrioid
1
2002
49
0.040
 Why?
Biopsy, Needle
1
2002
186
0.040
 Why?
Survival Analysis
3
2010
1386
0.040
 Why?
Plasmids
1
2002
373
0.040
 Why?
Child
1
2021
22979
0.040
 Why?
Magnetic Resonance Imaging
2
2010
3980
0.040
 Why?
Cross-Sectional Studies
2
2025
6011
0.040
 Why?
Patient Care Management
1
2001
56
0.040
 Why?
Thyroid Function Tests
2
2017
19
0.040
 Why?
Life Style
1
2023
504
0.040
 Why?
MutS Homolog 2 Protein
1
2020
12
0.040
 Why?
MCF-7 Cells
1
2020
133
0.040
 Why?
Macrophages
2
2020
1529
0.040
 Why?
Specialization
1
2001
137
0.040
 Why?
Mice, Transgenic
1
2005
2197
0.040
 Why?
Health Status
1
2006
839
0.040
 Why?
Calcitonin
1
2020
27
0.040
 Why?
Models, Animal
1
2022
394
0.040
 Why?
Pituitary Hormones
1
1999
15
0.040
 Why?
Receptors, Virus
1
2020
95
0.040
 Why?
Mice, SCID
1
2020
369
0.040
 Why?
Medicine
1
2001
126
0.040
 Why?
Validation Studies as Topic
1
2019
23
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2020
196
0.040
 Why?
Singapore
1
2019
27
0.040
 Why?
Risk Factors
3
2023
11017
0.040
 Why?
Lymphoma, T-Cell, Cutaneous
1
1999
45
0.040
 Why?
Octreotide
1
1999
23
0.040
 Why?
Drug Therapy, Combination
1
2022
1046
0.040
 Why?
Immune System
1
2020
181
0.040
 Why?
Mice, Inbred NOD
1
2020
616
0.040
 Why?
Cost-Benefit Analysis
1
2022
653
0.040
 Why?
Prevalence
1
2025
2889
0.030
 Why?
Leukocytes
1
2020
301
0.030
 Why?
Luminescence
1
2018
37
0.030
 Why?
Radiation Tolerance
1
1999
103
0.030
 Why?
Pharmacogenomic Variants
1
2018
35
0.030
 Why?
Kaplan-Meier Estimate
1
2020
975
0.030
 Why?
DNA Mismatch Repair
1
2018
54
0.030
 Why?
North America
1
2018
307
0.030
 Why?
Surveys and Questionnaires
3
2020
6164
0.030
 Why?
Age Factors
3
2015
3372
0.030
 Why?
Dietary Carbohydrates
1
1998
147
0.030
 Why?
Oncogenes
1
2018
118
0.030
 Why?
Interdisciplinary Communication
1
2018
201
0.030
 Why?
Liver
1
2005
1916
0.030
 Why?
Delphi Technique
1
2018
347
0.030
 Why?
Gene Frequency
1
2018
498
0.030
 Why?
Soft Tissue Neoplasms
1
2018
133
0.030
 Why?
DNA
4
1996
1444
0.030
 Why?
Advisory Committees
1
2018
233
0.030
 Why?
Tissue Distribution
1
1997
335
0.030
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.030
 Why?
Health Policy
1
2020
405
0.030
 Why?
Stroboscopy
1
2016
8
0.030
 Why?
Doxorubicin
1
1999
411
0.030
 Why?
DNA Fingerprinting
1
1996
28
0.030
 Why?
Deoxyribonuclease I
1
1996
42
0.030
 Why?
RNA
1
2002
916
0.030
 Why?
Immunomodulation
1
2016
100
0.030
 Why?
Tumor Suppressor Proteins
1
2018
323
0.030
 Why?
Antithyroid Agents
2
2006
12
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
539
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2015
28
0.030
 Why?
Surgeons
1
2020
342
0.030
 Why?
Chromosomes, Human, Pair 4
1
1995
26
0.030
 Why?
Mutagenesis, Site-Directed
1
1996
377
0.030
 Why?
Clinical Trials as Topic
1
2020
1072
0.030
 Why?
Lymphocyte Count
1
2015
165
0.030
 Why?
Mutagenesis, Insertional
1
1994
69
0.030
 Why?
Cytotoxicity, Immunologic
1
2015
224
0.030
 Why?
Gene Expression Regulation
4
1997
2625
0.030
 Why?
Microsatellite Repeats
1
2014
159
0.030
 Why?
Adipose Tissue
1
1998
646
0.030
 Why?
Risk
2
2006
927
0.020
 Why?
Age of Onset
1
2015
568
0.020
 Why?
Head and Neck Neoplasms
1
2018
569
0.020
 Why?
Proto-Oncogene Proteins c-bcl-2
1
1995
241
0.020
 Why?
Mice, Knockout
1
2020
3153
0.020
 Why?
Genes, Neoplasm
1
2013
26
0.020
 Why?
Killer Cells, Natural
1
2016
481
0.020
 Why?
Computational Biology
1
2018
677
0.020
 Why?
Gene Deletion
1
1994
392
0.020
 Why?
Preoperative Period
1
2013
150
0.020
 Why?
Neutropenia
1
2013
154
0.020
 Why?
DNA, Single-Stranded
1
1993
117
0.020
 Why?
Case-Control Studies
2
2015
3660
0.020
 Why?
Postoperative Period
1
2013
351
0.020
 Why?
Alternative Splicing
1
1994
248
0.020
 Why?
Focal Adhesion Kinase 1
1
2012
32
0.020
 Why?
Reference Values
2
2005
800
0.020
 Why?
Genetic Markers
1
2013
338
0.020
 Why?
Dasatinib
1
2012
58
0.020
 Why?
Autophagy
1
2014
291
0.020
 Why?
Recurrence
1
2015
1151
0.020
 Why?
Repressor Proteins
1
1995
429
0.020
 Why?
Age Distribution
1
2012
406
0.020
 Why?
Sex Distribution
1
2012
390
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1995
415
0.020
 Why?
Tumor Burden
1
2012
327
0.020
 Why?
Primary Health Care
1
2001
1759
0.020
 Why?
Longevity
1
2012
178
0.020
 Why?
Universities
1
2013
453
0.020
 Why?
Interleukin-6
1
2014
784
0.020
 Why?
Obesity
1
2023
3149
0.020
 Why?
Protein Processing, Post-Translational
1
2012
480
0.020
 Why?
Cell Survival
1
2012
1111
0.020
 Why?
Menopause
1
2012
328
0.020
 Why?
Physical Examination
1
2009
245
0.020
 Why?
Calreticulin
1
2008
22
0.020
 Why?
Binding Sites
3
1996
1319
0.020
 Why?
Exons
2
2002
365
0.020
 Why?
Drug Administration Schedule
1
2009
789
0.020
 Why?
Early Detection of Cancer
1
2013
506
0.020
 Why?
Insulin
1
1998
2526
0.020
 Why?
Cytokines
1
2015
2086
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor Proteins
1
2006
8
0.010
 Why?
Chromans
1
2006
25
0.010
 Why?
Radiotherapy Dosage
1
2006
289
0.010
 Why?
International Cooperation
1
2006
198
0.010
 Why?
Angiogenesis Inhibitors
1
2006
239
0.010
 Why?
Feasibility Studies
1
2009
1147
0.010
 Why?
Radiography
1
2006
862
0.010
 Why?
Inflammation
1
2014
2920
0.010
 Why?
Neoplasm, Residual
1
2003
144
0.010
 Why?
Biopsy
1
2006
1093
0.010
 Why?
Culture Techniques
1
2002
66
0.010
 Why?
Peptides
1
2008
1003
0.010
 Why?
Models, Biological
1
2008
1772
0.010
 Why?
Pain
1
2006
794
0.010
 Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
 Why?
Steroidogenic Factor 1
1
1999
13
0.010
 Why?
Gonadotropins
1
1999
44
0.010
 Why?
Postmenopause
1
2002
394
0.010
 Why?
Analysis of Variance
1
2002
1302
0.010
 Why?
DNA Primers
1
1999
505
0.010
 Why?
Follicle Stimulating Hormone
1
1999
266
0.010
 Why?
Organ Specificity
1
1998
310
0.010
 Why?
GATA2 Transcription Factor
1
1997
14
0.010
 Why?
Logistic Models
1
2002
2142
0.010
 Why?
Sequence Deletion
1
1996
192
0.010
 Why?
3T3 Cells
1
1995
157
0.010
 Why?
Muridae
1
1995
6
0.010
 Why?
Replication Protein C
1
1995
4
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
1995
118
0.010
 Why?
Hybrid Cells
1
1995
49
0.010
 Why?
Macromolecular Substances
1
1995
216
0.010
 Why?
Minor Histocompatibility Antigens
1
1995
47
0.010
 Why?
Mice, Inbred DBA
1
1994
182
0.010
 Why?
Mutagenesis
1
1995
196
0.010
 Why?
Body Weight
1
1998
976
0.010
 Why?
Cloning, Molecular
1
1994
539
0.010
 Why?
Blotting, Northern
1
1993
203
0.010
 Why?
Survival Rate
1
1998
2110
0.010
 Why?
Haplotypes
1
1995
509
0.010
 Why?
Sex Factors
1
1998
2136
0.010
 Why?
Protein Biosynthesis
1
1993
452
0.000
 Why?
Rats
1
1996
5613
0.000
 Why?
Mice, Inbred C57BL
1
1995
6041
0.000
 Why?
Haugen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (516) concept(s)
_
Co-Authors Expand Description
See all (50) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)